PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") today provided an update on its financial position. As reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2026 (PMCB’s fiscal year ends April 30), PharmaCyte held total assets of approximately $36.7 million, including approximately $17.7 million in cash and cash equivalents. Stockholders’ equity totaled approximately $27.5 million as of July 31, 2026. PharmaCyte has approximately 566,000 shares of common stock outstanding.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.